Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text

Medicine, Ophthalmology, Surgery +12

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine · 2011 · 2.6K citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

Geeta A. Lalwani, Philip J. Rosenfeld, Anne E. Fung et al. · American Journal of Ophthalmology · 2009 · 884 citations

Medicine, Ophthalmology, Pharmacotherapy +13

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

Carl D. Regillo, David M. Brown, Prema Abraham et al. · American Journal of Ophthalmology · 2008 · 862 citations

Medicine, Ophthalmology, Surgery +10

Myositis Ossificans

Deborah A. Martin, Sanjaya Senanayake · New England Journal of Medicine · 2011 · 276 citations · Full text